A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
allow, during a lapse in appropriations, acceptance of 
certain device submissions and registrations with the cor-
responding fees made available for obligation and expend-
iture for the process for the review of device applications, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Medical Innovation 
4
Never Stops Act of 2019’’. 
5
21:36 Mar 05, 2019
H1362
2 
•HR 1362 IH
SEC. 2. AUTHORITY DURING A LAPSE IN APPROPRIATIONS. 
1
Chapter VII of the Federal Food, Drug, and Cos-
2
metic Act is amended by inserting after section 738A (21 
3
U.S.C. 379j–1) the following: 
4
‘‘SEC. 738B. AUTHORITY DURING A LAPSE IN APPROPRIA-
5
TIONS. 
6
‘‘(a) ACCEPTANCE OF SUBMISSIONS AND REGISTRA-
7
TIONS; APPLICATION OF FEES.—During any period in 
8
which appropriations are not in effect for the Food and 
9
Drug Administration, the Secretary shall— 
10
‘‘(1) accept a submission described in section 
11
738(a)(2) and a registration described in section 
12
738(a)(3) if an applicable fee has been submitted for 
13
such submission or registration; 
14
‘‘(2) collect such fees in accordance with this 
15
part, notwithstanding any limitation with respect to 
16
the availability of appropriations in section 738; and 
17
‘‘(3) obligate and expend such fees as may be 
18
so collected for the process for the review of device 
19
applications. 
20
‘‘(b) APPLICATION OF PREVIOUSLY PAID FEES.— 
21
‘‘(1) IN GENERAL.—During any period in which 
22
appropriations are not in effect for the Food and 
23
Drug Administration, the Secretary may obligate 
24
and expend for the process for the review of device 
25
applications any fees— 
26
21:36 Mar 05, 2019
H1362
3 
•HR 1362 IH
‘‘(A) that were paid before such period 
1
began for submissions described in section 
2
738(a)(2), but with respect to which a submis-
3
sion has not been received; and 
4
‘‘(B) that were paid before such period 
5
began for registrations described in section 
6
738(a)(3), but with respect to which a remitter 
7
has not been identified. 
8
‘‘(2) SUBSEQUENTLY RECEIVED SUBMISSION OR 
9
REGISTRATION.—Notwithstanding the obligation or 
10
expenditure of a fee for the process for the review 
11
of device applications pursuant to paragraph (1), 
12
such fee shall be deemed to have been paid for pur-
13
poses of section 738(f)(1) if the Secretary subse-
14
quently receives a submission or registration for 
15
such fee. 
16
‘‘(c) EFFECT OF ENACTMENT OF SUBSEQUENT AP-
17
PROPRIATIONS.—Upon the enactment of an appropriation 
18
for fees under section 738 for a fiscal year, or a general 
19
appropriation bill providing appropriations for the Food 
20
and Drug Administration for a fiscal year without provi-
21
sion for such device fees, following a period during which 
22
a collection, obligation, or expenditure of fees occurs pur-
23
suant to subsection (a) or (b) for such fiscal year— 
24
21:36 Mar 05, 2019
H1362
4 
•HR 1362 IH
‘‘(1) such collection, obligation, and expenditure 
1
shall be charged to such appropriation (if any); and 
2
‘‘(2) amounts made available pursuant to such 
3
subsection shall not be available after the date of the 
4
enactment of such appropriation or general appro-
5
priation bill.’’. 
6
Æ 
21:36 Mar 05, 2019
H1362
